117 related articles for article (PubMed ID: 8604740)
21. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
22. Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinic.
Evans WE; Pui CH; Relling MV
Adv Exp Med Biol; 1999; 457():537-41. PubMed ID: 10500831
[No Abstract] [Full Text] [Related]
23. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
de Smet MD; Vancs VS; Kohler D; Solomon D; Chan CC
Br J Ophthalmol; 1999 Apr; 83(4):448-51. PubMed ID: 10434868
[TBL] [Abstract][Full Text] [Related]
24. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye.
Thiel MA; Wild A; Schmid MK; Job O; Bochmann F; Loukopoulos V; Alcantara W; Schmidt A; Lichtlen P; Escher D
Ophthalmology; 2013 Jul; 120(7):1403-8. PubMed ID: 23490328
[TBL] [Abstract][Full Text] [Related]
25. [Investigation on individualized adjustment of target range of high-dose methotrexate].
Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
[TBL] [Abstract][Full Text] [Related]
27. Leukemic glaucoma in a patient with chronic myeloid leukemia treated by intracameral methotrexate.
Lee MH; Park MY; Lee JW
Jpn J Ophthalmol; 2010 Jul; 54(4):362-4. PubMed ID: 20700810
[No Abstract] [Full Text] [Related]
28. Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma.
Keino H; Okada AA; Watanabe T; Echizen N; Inoue M; Takayama N; Nagane M
Ocul Immunol Inflamm; 2016 Jun; 24(3):268-73. PubMed ID: 25760916
[TBL] [Abstract][Full Text] [Related]
29. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
Reddy R; Kim SJ
Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
[TBL] [Abstract][Full Text] [Related]
31. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.
Bae JH; Lee SC
Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204
[TBL] [Abstract][Full Text] [Related]
32. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
33. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of methotrexate in solid tumors.
Jain RK; Wei J; Gullino PM
J Pharmacokinet Biopharm; 1979 Apr; 7(2):181-94. PubMed ID: 20218013
[TBL] [Abstract][Full Text] [Related]
35. [Initial experience of treatment of primary intraocular lymphomas associated with primary CNS lymphomas].
Tropinskaia OF; Grishina EE; Serova NK; Kobiakov GL; Aronov MS; Shishkina LV
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):19-25; discussion 25. PubMed ID: 23033588
[TBL] [Abstract][Full Text] [Related]
36. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
37. Primary intraocular lymphoma: current and future perspectives.
Dunleavy K; Wilson WH
Leuk Lymphoma; 2006 Sep; 47(9):1726-7. PubMed ID: 17064977
[No Abstract] [Full Text] [Related]
38. Measurement of intraocular concentrations of etoposide after systemic and local administration.
Mao Y; Wu Z; Yang H; Lin S; Zheng J
Yan Ke Xue Bao; 2004 Sep; 20(3):178-80, 186. PubMed ID: 15499727
[TBL] [Abstract][Full Text] [Related]
39. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.
Balis FM; Blaney SM; McCully CL; Bacher JD; Murphy RF; Poplack DG
Cancer Chemother Pharmacol; 2000; 45(3):259-64. PubMed ID: 10663645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]